Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
| AFGFX Fund | USD 78.32 0.45 0.57% |
Slightly above 62% of Allianzgi Focused's investor base is looking to short. The analysis of overall sentiment of trading Allianzgi Focused Growth mutual fund suggests that many investors are alarmed at this time. Allianzgi Focused's investing sentiment can be driven by a variety of factors including economic data, Allianzgi Focused's earnings reports, geopolitical events, and overall market trends.
Allianzgi |
DUBLIN, August 23, 2023 Horizon Therapeutics plc today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company. Rare disease patient groups who worked with Horizon also ranked the company first in 10 of the 14 indicators including patient centricity, patient information, integrity, access to medicines, relationships and services bey
Read at finance.yahoo.com
 |
Allianzgi Focused Fundamental Analysis
We analyze Allianzgi Focused's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allianzgi Focused using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allianzgi Focused based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Allianzgi Focused is third largest fund in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Allianzgi Focused Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allianzgi Focused mutual fund to make a market-neutral strategy. Peer analysis of Allianzgi Focused could also be used in its relative valuation, which is a method of valuing Allianzgi Focused by comparing valuation metrics with similar companies.
Peers
Allianzgi Focused Related Equities
| AEMOX | Allianzgi Emerging | 0.21 | ||||
| ASHSX | Allianzgi Short | 0.07 | ||||
| AIISX | Allianzgi International | 0.37 | ||||
| AGASX | Allianzgi Global | 0.39 | ||||
| ANAVX | Allianzgi Nfj | 0.47 | ||||
| AFGFX | Allianzgi Focused | 0.57 | ||||
| ANDVX | Allianzgi Nfj | 0.64 | ||||
| ANFVX | Allianzgi Nfj | 0.80 |
Other Information on Investing in Allianzgi Mutual Fund
Allianzgi Focused financial ratios help investors to determine whether Allianzgi Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allianzgi with respect to the benefits of owning Allianzgi Focused security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |